Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,857
Closed -$233K 155
2025
Q4
$233K Hold
1,857
0.03% 144
2025
Q3
$249K Buy
+1,857
New +$244K 0.04% 130
2023
Q1
Sell
-715
Closed -$78.5K 113
2022
Q4
$78.5K Hold
715
0.02% 146
2022
Q3
$69K Hold
715
0.02% 131
2022
Q2
$78K Hold
715
0.02% 172
2022
Q1
$85K Hold
715
0.02% 171
2021
Q4
$101K Hold
715
0.03% 164
2021
Q3
$84K Hold
715
0.02% 173
2021
Q2
$83K Sell
715
-91
-11% -$10.6K 0.02% 175
2021
Q1
$97K Hold
806
0.03% 165
2020
Q4
$88K Buy
806
+91
+13% +$9.89K 0.03% 171
2020
Q3
$78K Sell
715
-91
-11% -$9.23K 0.03% 174
2020
Q2
$74K Buy
806
+91
+13% +$8.22K 0.03% 178
2020
Q1
$56K Sell
715
-14
-2% -$1.17K 0.03% 161
2019
Q4
$63 Buy
+729
New +$61.1K 0.03% 179

Other funds holding ABT

Leelyn Smith's ABT Position: Q1 2026 in Review

Leelyn Smith sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,857 shares — an estimated $233K sold.

Leelyn Smith first reported a position in ABT in Q4 2019 and held it in 15 quarters. The position peaked at $249K in Q3 2025. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Leelyn Smith reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Leelyn Smith sold 1,857 Abbott shares in Q1 2026, an estimated $233K.
  • Leelyn Smith first reported a position in Abbott in Q4 2019 and held it in 15 quarters.
  • Leelyn Smith's Abbott position peaked at $249K in Q3 2025.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Leelyn Smith's 13F filing for Q1 2026, filed 27 Apr 2026.